Oncologists' recognition of depression in their patients with cancerS D Passik
Community Cancer Care, Inc, Indianapolis, IN 46202, USA
J Clin Oncol 16:1594-600. 1998
....
- A pilot study of oncology staff perceptions of palliative care and psycho-oncology services in rural and community settings in Indiana
Steven D Passik
Community Cancer Care, Inc, Oncology Symptom Control Research, Indianapolis, IN 46202, USA
J Rural Health 18:31-4. 2002
..Conclusions are tempered by important study limitations but the results suggest the need for programs that improve delivery of palliative care in rural Indiana...
- An open label pilot study of citalopram for depression and boredom in ambulatory cancer patients
Dale E Theobald
Oncology Symptom Control and Research, Community Cancer Care, Indianapolis, Indiana, USA
Palliat Support Care 1:71-7. 2003
..Depression began to improve almost immediately upon initiation of treatment whereas improvement in boredom does not become evident until week 6...
- A pilot exploration of the antiemetic activity of olanzapine for the relief of nausea in patients with advanced cancer and pain
Steven D Passik
Oncology Symptom Control and Research, Community Cancer Care, Indianapolis, IN, USA
J Pain Symptom Manage 23:526-32. 2002
..0, p < 0.005). No extrapyramidal symptoms were noted and mental status exams were not changed over the course of the eight days. These results suggest an antiemetic effect for olanzapine and indicate the need for a controlled trial...
- An open-label, crossover trial of mirtazapine (15 and 30 mg) in cancer patients with pain and other distressing symptoms
Dale E Theobald
Oncology Symptom Control and Research, Community Cancer Care, Indianapolis, Indiana 46202, USA
J Pain Symptom Manage 23:442-7. 2002
..This open-label pilot study suggests that mirtazapine may be effective for improving multiple symptoms, depression and quality of life in patients with advanced cancer. A controlled trial of this drug would be valuable...
- A phase I trial of olanzapine (Zyprexa) for the prevention of delayed emesis in cancer patients: a Hoosier Oncology Group study
Steven D Passik
Hoosier Oncology Group, Walther Cancer Institute, Indianapolis, Indiana, USA
Cancer Invest 22:383-8. 2004
..Therefore, olanzapine may be an effective agent for the prevention of chemotherapy-induced DE. A phase II trial is underway...
- Management of chronic noncancer pain in the primary care setting
Bruce Nicholson
Pain Specialists of Greater Lehigh Valley, Allentown, PA 18103, USA
South Med J 100:1028-36. 2007
..Ongoing monitoring should focus on the 4 A's (ie, analgesia, activities of daily living, adverse effects, and aberrant drug-related behaviors), and all aspects of patient care must be thoroughly documented...
Substance abuse issues in oral and maxillofacial practiceRobert J Defalco
St Joseph s Regional Medical Center, Department of Oral and Maxillofacial Surgery, 703 Main Street, Paterson, NJ 07503, USA
Oral Maxillofac Surg Clin North Am 22:527-35. 2010
..Identification of impaired providers is essential to help them find the appropriate treatment and counseling and to prevent harm to their patients, family, friends, or associates...
- Substance abuse issues in cancer pain
Laurie A Whitcomb
Community Cancer Care, Inc, Oncology Symptom Control Research, 115 West 19th Street, Indianapolis, IN 46202, USA LAWhitMAI
Curr Pain Headache Rep 6:183-90. 2002
..In this paper, we will explore pertinent conceptual and clinical aspects of addiction that can assist in improving the identification and treatment of patients with substance use disorders...
- Abuse and addiction issues in medically ill patients with pain: attempts at clarification of terms and empirical study
Kenneth L Kirsh
Symptom Management and Palliative Care Program, Markey Cancer Center, University of Kentucky, Lexington, Kentucky 40536-0093, USA
Clin J Pain 18:S52-60. 2002
....
- Pain and aberrant drug-related behaviors in medically ill patients with and without histories of substance abuse
Steven D Passik
Department of Psychiatry and Behavioral Sciences, Memorial Sloan-Kettering Cancer Center, New York, NY, USA
Clin J Pain 22:173-81. 2006
..Treatment of substance abusers with pain requires skills that complement best practices in opioid prescribing. Better approaches to the long-term treatment of these populations are needed...
- Pain management misstatements: ceiling effects, red and yellow flags
Steven D Passik
Memorial Sloan Kettering Cancer Center
Pain Med 7:76-7. 2006
- A chart review, pilot study of two single-item screens to detect cancer patients at risk for cachexia
Kenneth L Kirsh
Symptom Management and Palliative Care Program, Markey Cancer Center, University of Kentucky, Lexington 40536-0093, USA
Palliat Support Care 1:331-5. 2003
..Further study is needed in prospective trials to further explore the utility of these items...
- Difficulties in screening for adjustment disorder, Part II: An attempt to develop a novel self-report screening instrument in cancer patients undergoing bone marrow transplantation
Kenneth L Kirsh
Symptom Management and Palliative Care Program, Markey Cancer Center, University of Kentucky, Lexington, Kentucky 40536 0093, USA
Palliat Support Care 2:33-41. 2004
..Bone marrow transplantation (BMT) has a high level of morbidity that can cause significant stress for patients faced with the procedure...
- King of pain: what Elvis's death tells us about media coverage of celebrities and the pain/addiction interface
Steven D Passik
J Opioid Manag 3:69-70. 2007
- A pilot study to examine the relationship between boredom and spirituality in cancer patients
Alice Inman
Department of Behavioral Medicine, Brooke Army Medical Center, San Antonio, Texas, USA
Palliat Support Care 1:143-51. 2003
..More research is needed to clarify the nature of the interrelationships between these important concepts...
- Psychiatric and pain characteristics of prescription drug abusers entering drug rehabilitation
Steven D Passik
Memorial Sloan Kettering Cancer Center and Cornell University Weil College of Medicine, New York, NY, USA
J Pain Palliat Care Pharmacother 20:5-13. 2006
..v. administration. Implications for pain management are discussed, focusing on the need for clinicians treating chronic pain to more thoroughly assess patients for their risk of abuse and addiction before starting an opioid regimen...
- Palliative care of the terminally ill drug addict
Kenneth L Kirsh
Pharmacy Practice and Science, University of Kentucky, Lexington, Kentucky 40536 0082, USA
Cancer Invest 24:425-31. 2006
..Implications for the field are discussed...
- Managing pain in patients with aberrant drug-taking behaviors
Steven D Passik
Symptom Management and Palliative Care Program, Markey Cancer Center, University of Kentucky, Lexington, Kentucky 40536-0093, USA
J Support Oncol 3:83-6. 2005
- A pilot examination of the impact of cancer patients' fatigue on their spousal caregivers
Steven D Passik
Memorial Sloan Kettering Cancer Center, Department of Psychiatry and Behavioral Sciences, 641 Lexington Avenue, New York, NY 10022, USA
Palliat Support Care 3:273-9. 2005
..In this pilot project we examined the quality of life of spouses of cancer patients who had significant fatigue...
- Assessing aberrant drug-taking behaviors in the patient with chronic pain
Steven D Passik
Symptom Management and Palliative Care Program, Markey Cancer Center, University of Kentucky, 800 Rose Street, CC125, Lexington, KY 40536 0093, USA
Curr Pain Headache Rep 8:289-94. 2004
..The assessment of aberrant behaviors in patients with chronic pain is one key aspect of mastering these principles...
- A new tool to assess and document pain outcomes in chronic pain patients receiving opioid therapy
Steven D Passik
Symptom Management and Palliative Care Program, Markey Cancer Center, University of Kentucky, 800 Rose Street, CC449, Lexington, KY 40536 0093, USA
Clin Ther 26:552-61. 2004
..During long-term treatment, this assessment should focus on a broad range of outcomes, each of which should be documented in the medical record...
- Opioid therapy in patients with a history of substance abuse
Steven D Passik
Symptom Management and Palliative Care Program, University of Kentucky College of Medicine, Lexington, Kentucky 40536 0093, USA
CNS Drugs 18:13-25. 2004
....
- Pain clinicians' rankings of aberrant drug-taking behaviors
Steven D Passik
Chandler Medical College, and Marky Cancer Center, University of Kentucky, Lexington, KY 40536 0093, USA
J Pain Palliat Care Pharmacother 16:39-49. 2002
..Further inquiry could be used to guide clinicians' responses to aberrant behaviors when encountered in patients on controlled substances for pain...
- Initial development of a survey tool to detect issues of chemical coping in chronic pain patients
Kenneth L Kirsh
Pharmacy Practice and Science, University of Kentucky, Lexington, Kentucky 40536 0082, USA
Palliat Support Care 5:219-26. 2007
..We have used the term chemical coping to describe this vast middle ground and seek to begin a line of research starting with the development of a clinically useful tool to identify this subset of patients...
Challenges in using opioids to treat pain in persons with substance use disordersSeddon R Savage
Dartmouth Medical School, Hanover, New Hampshire 03755, USA
Addict Sci Clin Pract 4:4-25. 2008
..The authors consider that every pain complaint deserves careful investigation and every patient in pain has a right to effective treatment...
- The need to identify predictors of aberrant drug-related behavior and addiction in patients being treated with opioids for pain
Steven D Passik
Markey Cancer Center, University of Kentucky, Lexington, Kentucky, USA
Pain Med 4:186-9. 2003
- Assessment of quality of life in outpatients with advanced cancer: the accuracy of clinician estimations and the relevance of spiritual well-being--a Hoosier Oncology Group Study
Michael J Fisch
The University of Texas M D Anderson Cancer Center, Unit 008, Rm P12 2911, 1515 Holcombe Blvd, Houston, TX 77030 4009, USA
J Clin Oncol 21:2754-9. 2003
..To evaluate the association between quality-of-life (QOL) impairment as reported by patients and QOL impairment as judged by nurses or physicians, with and without consideration of spiritual well-being (SWB)...
- An opioid screening instrument: long-term evaluation of the utility of the pain medication questionnaire by Holmes et al
Steven D Passik
Pain Pract 6:69-71. 2006
- Weighing in on the off-label use of Actiq for noncancer-related pain: a recipe for success or a recipe for disaster?
Steven D Passik
Psychiatry and Behavioral Sciences, Memorial Sloan Kettering Cancer Center, New York, New York 10022, USA
Pain Med 8:130-3. 2007
..A call is made to pain professionals to begin discussion of the common use of pharmaceuticals in off-label ways to treat pain issues as well as a discussion of the dangers of not addressing this practice openly...
- Challenges in the development of prescription opioid abuse-deterrent formulations
Nathaniel P Katz
Tufts University School of Medicine, Boston, MA, USA
Clin J Pain 23:648-60. 2007
....
- Monitoring outcomes during long-term opioid therapy for noncancer pain: results with the Pain Assessment and Documentation Tool
Steven D Passik
Memorial Sloan Kettering Cancer Center, New York, New York, USA
J Opioid Manag 1:257-66. 2005
..e., addiction or diversion) in only approximately 10 percent of cases. Using the PADT physician ratings can be developed in four domains. In this sample, outcomes suggested that opioid therapy provided meaningful analgesia...
- A phase II trial of olanzapine, dexamethasone, and palonosetron for the prevention of chemotherapy-induced nausea and vomiting: a Hoosier oncology group study
Rudolph M Navari
Notre Dame Cancer Institute, University of Notre Dame, 224 Raclin Carmichael Hall, Notre Dame, IN 46556, USA
Support Care Cancer 15:1285-91. 2007
....
- Commentary on Jung and Reidenberg's "Physicians being deceived": aberrant drug-taking behaviors: what pain physicians can know (or should know)
Steven D Passik
Memorial Sloan Kettering Cancer Center, New York, New York, USA
Pain Med 8:442-4; author reply 447-8. 2007
- Will the number of milligrams of an opioid dose ever re-achieve the truly meaningless status it deserves?
Steven D Passik
Memorial Sloan Kettering Cancer Center and Weil Medical College of Cornell University, New York, New York 10021, USA
J Pain Palliat Care Pharmacother 21:39-41. 2007
..This commentary posits that clinicians must return to the principles of balancing efficacy with toxicity as the dose-limiting factor once again, contextualized by outcomes in the areas of function and compliant drug-taking...
- Commentary: reflections on the Cicero et al. paper (PDS 06 0174.R2)
Steven D Passik
Psychiatry and Behavioral Sciences, Memorial Sloan Kettering Cancer Center, New York, NY 10022, USA
Pharmacoepidemiol Drug Saf 16:841-4. 2007
- Empathy and the failure to treat pain
Steven D Passik
Psychiatry and Behavioral Sciences, Memorial Sloan Kettering Cancer Center, New York, New York, USA
Palliat Support Care 5:167-72. 2007
..Ultimately, we hope to push forward an agenda of rational therapy in pain management that utilizes safeguards against abuse and addiction while also preserving treatment modalities for patients in need of services...
- Reality and responsibility: a commentary on the treatment of pain and suffering in a drug-using society
Steven D Passik
Memorial Sloan Kettering Cancer Center, New York, New York, USA
J Opioid Manag 2:123-7. 2006
....
- Fear and loathing in the pain clinic
Steven D Passik
Memorial Sloan Kettering Cancer Center, New York, NY, USA
Pain Med 7:363-4; discussion 365-6. 2006
- Re. Probing the paradox of patients' satisfaction with inadequate pain management
Steven D Passik
J Pain Symptom Manage 24:361-3. 2002
- Patient-related barriers to fatigue communication: initial validation of the fatigue management barriers questionnaire
Steven D Passik
Symptom Management and Palliative Care Program, Markey Cancer Center, University of Kentucky, Lexington, KY 40536, USA
J Pain Symptom Manage 24:481-93. 2002
..Multiple barriers contribute to why cancer patients do not comment about fatigue but may be overcome if physicians screen and assess for this symptom...
- Same as it ever was? Life after the OxyContin media frenzy
Steven D Passik
J Pain Symptom Manage 25:199-201. 2003
- An unsuccessful attempt to develop a single-item screen for insomnia in cancer patients
Steven D Passik
Symptom Management and Palliative Care Program, Markey Cancer Center, University of Kentucky, Lexington, KY, USA
J Pain Symptom Manage 25:284-7. 2003
..The use of this single item, or perhaps any single item, as a means of screening for sleep disturbances in cancer patients may be problematic. A better understanding of insomnia and its measurement are worthwhile areas of study...
- A retrospective chart review of the use of olanzapine for the prevention of delayed emesis in cancer patients
Steven D Passik
Symptom Management and Palliative Care Program, Markey Cancer Center, University of Kentucky, Lexington, KY 40536-0093, USA
J Pain Symptom Manage 25:485-8. 2003
..These data suggest that olanzapine was well tolerated and may reduce the incidence of delayed emesis in patients receiving moderate to highly emetogenic chemotherapy. A series of prospective trials are underway...
- My mind is as clear as it used to be: A pilot study illustrating the difficulties of employing a single-item subjective screen to detect cognitive impairment in outpatients with cancer
Gail Kibiger
University of Indianapolis, Indiana, USA
J Pain Symptom Manage 26:705-15. 2003
..We conclude that while the perception of cognitive impairment is common in cancer patients, there may be problems in interpreting the nature of these complaints, particularly in separating them from depressive preoccupation...
- Difficulties in screening for adjustment disorder, Part I: Use of existing screening instruments in cancer patients undergoing bone marrow transplantation
Kenneth L Kirsh
Symptom Management and Palliative Care Program, Markey Cancer Center, University of Kentucky, Lexington, Kentucky 40536 0093, USA
Palliat Support Care 2:23-31. 2004
..This is especially true with regard to identifying adjustment disorder (AD), despite the fact that AD is the most prevalent psychiatric diagnosis in cancer patients...
- A feasibility study of dignity psychotherapy delivered via telemedicine
Steven D Passik
Symptom Management and Palliative Care Program, Markey Cancer Center, University of Kentucky, Lexington, Kentucky 40536 0093, USA
Palliat Support Care 2:149-55. 2004
..We delivered the Dignity Psychotherapy intervention in a feasibility study of a series of eight cancer patients via videophone technology to deliver the therapy into their homes...
- Initial validation of a scale to measure purposelessness, understimulation, and boredom in cancer patients: toward a redefinition of depression in advanced disease
Steven D Passik
Symptom Management and Palliative Care Program, Markey Cancer Center, University of Kentucky, Lexington, Kentucky 40536 0093, USA
Palliat Support Care 1:41-50. 2003
..We were interested in developing a Purposelessness, Understimulation, and Boredom (PUB) Scale to identify this problem and to begin to differentiate it from depression...
- A pilot study of the impact of a grief camp for children
Laura Nabors
Department of Psychology, Mail Location 376, University of Cincinnati, Cincinnati, OH 45221 0376, USA
Palliat Support Care 2:403-8. 2004
..Research indicates that children benefit from supportive interventions to help them cope with the loss of a loved one. The aim of this pilot study was to evaluate children's perceptions of the effectiveness of a grief camp...
- Is there a model for demonstrating a beneficial financial impact of initiating a palliative care program by an existing hospice program?
Steven D Passik
Memorial Sloan Kettering Cancer Center, 1242 Second Avenue, New York, New York 10021, USA
Palliat Support Care 2:419-23. 2004
..We end with a series of questions: Are there financial benefits? Can they be modeled and quantified? Is this a dilemma for hospice programs wanting to improve the quality of care but who are not able on their own to finance it?..
- Hospice staff members' views on conducting end-of-life research
Kenneth L Kirsh
Symptom Management and Palliative Care Program, Markey Cancer Center, University of Kentucky, 800 Rose Street, CC129, Lexington, KY 40536 0093, USA
Palliat Support Care 2:273-82. 2004
..This survey study was designed to examine hospice staff attitudes, beliefs, and values about research with their patients and family members...
- Brief report: pain and readiness to quit smoking cigarettes
Ellen J Hahn
University of Kentucky College of Nursing, Lexington, KY 40536 0232, USA
Nicotine Tob Res 8:473-80. 2006
..Placing formal tobacco dependence treatment programs within pain clinics and addressing pain in smoking cessation programs is recommended...
- Use of a depression screening tool and a fluoxetine-based algorithm to improve the recognition and treatment of depression in cancer patients. A demonstration project
Steven D Passik
Symptom Management and Palliative Care Program, Markey Cancer Center, University of Kentucky, Lexington 40536, USA
J Pain Symptom Manage 24:318-27. 2002
..Such an approach may benefit patients, and, if kept simple, can be incorporated into day-to-day care of people with cancer...
